The Archive · 2 posts
Clinical innovation at its best! 🚀 Discover Theracryf PLC (TCF) advancing health solutions on the LSE. 🌟
TheraCryf rejects takeover bid for its neuropsychiatry assets, believing its Orexin-1 addiction programme holds greater future value for shareholders.
April 14, 2026
Showing 1 of 2 posts
TheraCryf extends cash runway to 2026 & advances Orexin-1 addiction treatment. Key patents secured, manufacturing scaled. Biotech catalyst watch.
JoshuaJune 3, 2025